FDA 503B outsourcing facilities in Kansas
Kansas has 1 FDA-registered 503B outsourcing facility in the PeptideGrids directory, 1 with FDA drug recalls on record, the earliest registered in 2015. 503B facilities compound sterile medications in bulk under FDA cGMP standards and are a primary supply route for compounded peptides and GLP-1s during drug shortages.
| Facility | City | FDA-registered since | FDA recalls |
|---|---|---|---|
| Fagron Compounding Services dba Fagron Sterile Services | Wichita | 2015 | 13 |
503B compounding in Kansas
A 503B outsourcing facility registers with the FDA under the Drug Quality and Security Act and is inspected against cGMP manufacturing standards. In addition to that federal registration, a facility shipping into or operating in Kansas must hold the appropriate state pharmacy license. Verify any facility's current license with the Kansas Board of Pharmacy.
Peptides and GLP-1s compounded in Kansas
Facilities in Kansas report compounding Oxytocin, Semaglutide to the FDA. PeptideGrids grades the clinical evidence for each. Browse the full GLP-1 and therapeutic peptide databases.
Frequently asked questions
How many FDA 503B outsourcing facilities are in Kansas?
1 FDA-registered 503B outsourcing facility is listed in Kansas on PeptideGrids, the earliest registered in 2015.
Which Kansas 503B facilities have FDA recalls on record?
1 of the 1 Kansas facility has FDA drug recalls on record; the table above shows the count per facility.
How do I verify a pharmacy license in Kansas?
Use the Kansas Board of Pharmacy license lookup to confirm a facility's current license status.
Facilities sourced from the FDA registered outsourcing facilities list. Recall counts from the FDA openFDA drug enforcement database.